[1]
«Satisfaction assessment with subcutaneous immunotherapy by ESPIA questionnaire in a pediatric population with allergic phenotype asthma»., Rev Alerg Mex, vol. 73, n.º 2, pp. 120–128, jun. 2026, doi: 10.29262/ram.v73i2.1591.